GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » COGS-to-Revenue

Neurologix (Neurologix) COGS-to-Revenue : 0.00 (As of Jun. 2011)


View and export this data going back to . Start your Free Trial

What is Neurologix COGS-to-Revenue?

Neurologix's Cost of Goods Sold for the three months ended in Jun. 2011 was $0.00 Mil. Its Revenue for the three months ended in Jun. 2011 was $0.00 Mil.

Neurologix's COGS to Revenue for the three months ended in Jun. 2011 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Neurologix's Gross Margin % for the three months ended in Jun. 2011 was N/A%.


Neurologix COGS-to-Revenue Historical Data

The historical data trend for Neurologix's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix COGS-to-Revenue Chart

Neurologix Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Neurologix Quarterly Data
Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neurologix COGS-to-Revenue Calculation

Neurologix's COGS to Revenue for the fiscal year that ended in Dec. 2010 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Neurologix's COGS to Revenue for the quarter that ended in Jun. 2011 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neurologix  (GREY:NRGXQ) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Neurologix's Gross Margin % for the three months ended in Jun. 2011 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Neurologix COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neurologix's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurologix (Neurologix) Business Description

Traded in Other Exchanges
N/A
Address
One Bridge Plaza, Fort Lee, NJ, USA, 07024
Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines